FOS and neoplasm: Fra-1 and c-Fos overexpression together with PCNA immunoreaction are clearly observed in tumor samples, whereas PCNA immunoreactivity and c-Fos and Fra-1 expression levels are almost undetectable in the non-pathological counterparts (20).